A company presentation will take place during the conference’s Innovation track on Friday, March 28th at 9:00am. NeauxCancer conference’s Innovation track spotlights the most promising emerging ...

ORLANDO, FL / ACCESS Newswire / March 14, 2025 / RedChip Companies will air interviews with Nexalin Technology, Inc. (Nasdaq:NXL) and Calidi Biotherapeutics, Inc. (NYSE American:CLDI) on the RedChip S ...

RedChip Companies will air interviews with Nexalin Technology, Inc. (Nasdaq:NXL) and Calidi Biotherapeutics, Inc. (NYSE American:CLDI) on the RedChip Small Stocks, Big Money™ show, a sponsored program ...

Recently announced positive data from pivotal randomized, placebo-controlled phase 3 clinical trial of CAN-2409 in intermediate-to-high risk, ...

Calidi Biotherapeutics (NYSE American: CLDI) announced positive preclinical results for its systemic RTNova platform, demonstrating effective delive ...

(NYSE American: CLDI) announced positive preclinical results for its systemic RTNova platform, demonstrating effective delivery of transient gene therapy payloads to targeted tumors. The ...

HELSINKI and NAPLES, Italy and PERTH, Australia, March 10, 2025 (GLOBE NEWSWIRE) -- Valo Therapeutics Oy announces that it has successfully secured a financing round of €19 million, part of which was ...

Theriva Biologics is putting more of its eggs in the VCN-01 basket as it unveils a change-up in its R&D focus. | Theriva ...

Q1 Investor Summit Virtual Format: Presentation Presenter: Steve Shallcross, CEO and Manel Cascallo, PhD., General Director Presentation Date and Time: Tuesday, March 11, 2025, 12:30 PM ET Webcast: ...

Leavenworth’s contributions bridge laboratory research with clinical applications, paving the way for innovative cancer ...

Oncolytic virotherapy represents an innovative and promising approach for the treatment of cancer, including multiple myeloma (MM), a currently incurable plasma cell (PC) neoplasm. Despite the ...

The protection is for patent application number 201880064280.9, which protects the CD19-expressing oncolytic virus, onCARlytics. Titled “Oncolytic Virus Expressing a CAR-T cell target and uses thereof ...